Tumor Biology and Microenvironment Program Themes

Theme 1: To identify molecular, cellular determinants of malignancy (metastasis drivers)

Our investigators study key signaling pathways involved in tumorigenicity, tumor cell phenotypical plasticity, and tumor cell drug response (metastasis operatives).

Theme 1 Accomplishments 

Theme 2: To identify and exploit the underlying mechanisms of tumor metastasis (operatives)

Our investigators study the function and underlying mechanisms such as the extracellular proteolysis/signaling network that enable tumor cells to adapt to and eventually overcome the varying microenvironments.

Theme 2 Accomplishments 

Theme 3: To identify and exploit stromal reactivity and host immunity to tumor progression (host response to metastatic tumors)

Our investigators study the interaction of tumor cells with mesenchyme and innate immune cells. We also identify, evaluate and utilize adaptive cellular and humoral immune responses to develop immunotherapy approaches.

Theme 3 Accomplishments 

The Latest From Karmanos Cancer Institute

News

IN THE NEWS: Pancreatic Cancer Breakthrough

FOX 2 A researcher and his team in Spain have identified a combination of drug therapies that is showing promise in preclinical studies for treati...

Read More

Strengthening Clinical Trial Communication: Karmanos and McLaren Launch First Joint Oncology, Non-Oncology Study

The Karmanos Cancer Network and the McLaren Center for Research and Innovation (MCRI) have officially partnered on their first collaborative resea...

Read More

IN THE NEWS: What You May Not Know About HPV and Cervical Cancer Screening

WWJ The human papillomavirus (HPV) causes many cancers – one of those is cervical cancer. Radhika Gogoi, M.D., Ph.D. , gynecologic oncologist and ...

Read More
News

WWJ | What You May Not Know About HPV and Cervical Cancer Screening

Listen Now

94.7 WCSX | Cervical Cancer Awareness Month

Listen Now

WSGW | Risks of Pancreatic Cancer

Listen Now